Antiprotozoals are often categorized into and other antiprotozoal drugs .
Malaria remains the most prevalent, with an estimated 249 million cases in 2022. Other major targets include Chagas disease, leishmaniasis, giardiasis, and trichomoniasis. antiprotozoal drug
The global antiprotozoal drugs market is experiencing significant growth, driven by the rising burden of diseases like malaria and leishmaniasis. antiprotozoal drug